InvestorsHub Logo

cowtown jay

03/17/22 12:35 PM

#35807 RE: DonDonDonDon #35806

I agree that Humanigen will have a lock on most of the market for newly-hospitalized Covid patients.

I hope that our market will expand to treat vaccinated patients who develop breakthrough infections. A one-and-done bolus treatment that will negate the need for a second, third, or fourth vaccine, and prove to be more effective and durable, regardless of the variant. And perhaps in regards to different viruses, as well.